Lv1
100 积分 2024-09-09 加入
PS-C21-5: EFFICACY OF SWITCHING FROM EPLERENONE TO ESAXERENONE FOR THE TREATMENT OF PRIMARY ALDOSTERONISM
11天前
已关闭
Metabolic phenotypes and fatty acid profiles associated with histopathology of primary aldosteronism
20天前
已完结
Plasmacytoid dendritic cell content is associated with plasma aldosterone concentration in patients with primary aldosteronism
20天前
已关闭
Changes in Parathyroid Hormone Across the Spectrum of Renin-Independent Aldosteronism
21天前
已关闭
Medical Treatment of Primary Aldosteronism
22天前
已完结
Association between plasma aldosterone and markers of tubular and glomerular damage in primary aldosteronism
1个月前
已完结
The effect of different treatment strategies on glycolipid metabolism disorders and cardiovascular events in primary aldosteronism
1个月前
已完结
The decline in estimated glomerular filtration rate over the course of surgical and medical treatments in patients with primary aldosteronism
1个月前
已关闭
PRIMARY ALDOSTERONISM: THE EFFECT OF SPECIFIC TREATMENT ON RENAL FUNCTION
1个月前
已关闭
Kidney function predicts new-onset cardiorenal events and mortality in primary aldosteronism: approach of the 2021 race-free eGFR equation
1个月前
已完结
皖公网安备34019202002308
